Search
for

    Learn

    5 / 6 results

      learn Osteopontin

      signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

      learn SCUBE3

      a signaling molecule from dermal papilla cells being actively researched

      learn KY19382

      compound that activates Wnt/β-catenin to promote hair regrowth and create new hair follicles

      learn PP405

      mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials

    Research

    5 / 1000+ results

    Community Join

    5 / 201 results

      community Hair Loss Treatment Iceberg Chart

      in Satire  1382 upvotes 3 years ago
      Hair loss treatments discussed include Minoxidil, Finasteride, RU58841, ass hair transplant, topical Viagra, castration, and transitioning to female. A user mentions an experimental drug called M4U-5 (Mousteride) that turns you into a mouse.

      community Is anyone buying this comb over?

      in Styling  310 upvotes 2 years ago
      User has diffuse thinning crown and uses combover with hair spray. Oral minoxidil showed amazing results for another user.

      community Uh oh! 20 days?! Could it be so LOL

      in Satire  776 upvotes 3 weeks ago
      Hair loss treatments like olive oil, coconut oil, and finasteride are discussed with skepticism and humor. The conversation highlights disbelief in quick fixes and the ongoing search for effective solutions.

      community It's always the Mice that gets to grow back hair.

      in Research/Science  433 upvotes 3 weeks ago
      Sodium dodecyl sulfate, oleic acid, and palmitoleic acid may promote hair growth, but their safety and effectiveness for humans are uncertain. Users consider trying these treatments cautiously, exploring alternatives like ostrich oil and microneedling.

      community PP405 Phase 2a press release with early results

      in Research/Science  694 upvotes 5 months ago
      PP405 shows promise in hair regrowth, with 31% of participants experiencing over 20% increase in hair density after 8 weeks. Phase 3 trials are expected in 2026, with potential market availability by 2029-2031.